Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action

類似資料

• A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4(+)CD25(+) cells and TGF-β
  著者:: Sharabi, Amir, 等
  出版事項: (2006)
• The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models
  著者:: Sela, Uri, 等
  出版事項: (2009)
• The Tolerogenic Peptide, hCDR1, Down-Regulates the Expression of Interferon-α in Murine and Human Systemic Lupus Erythematosus
  著者:: Sthoeger, Zev, 等
  出版事項: (2013)
• Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients
  著者:: MAUERMANN, N, 等
  出版事項: (2004)
• A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis
  著者:: Ben-David, Hava, 等
  出版事項: (2009)